|
|
|
|
| LEADER |
01435nam a2200301 u 4500 |
| 001 |
EB000942882 |
| 003 |
EBX01000000000000000736472 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
150223 r ||| eng |
| 020 |
|
|
|a 9781587633669
|
| 100 |
1 |
|
|a Wilt, Timothy J.
|
| 245 |
0 |
0 |
|a Management of chronic hepatitis B
|h Elektronische Ressource
|c prepared for Agency for Healthcare Research Quality, U.S. Department of Health and Human Services ; prepared by Minnesota Evidence-based Practice Center, Minneapolis, Minnesota ; investigators, Timothy J. Wilt ... [et al.]
|
| 260 |
|
|
|a Rockville, MD
|b Agency for Healthcare Research and Quality
|c 2008, [2008]
|
| 300 |
|
|
|a viii, 129 p.
|b ill
|
| 505 |
0 |
|
|a Includes bibliographical references (p. 121-128)
|
| 653 |
|
|
|a Hepatitis B, Chronic / drug therapy
|
| 653 |
|
|
|a Treatment Outcome
|
| 653 |
|
|
|a Drug-Related Side Effects and Adverse Reactions
|
| 710 |
2 |
|
|a Minnesota Evidence-based Practice Center
|
| 710 |
2 |
|
|a United States
|b Agency for Healthcare Research and Quality
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a Evidence report/technology assessment
|
| 500 |
|
|
|a "October 2008."
|
| 856 |
4 |
0 |
|u http://purl.access.gpo.gov/GPO/LPS105160
|3 Volltext
|n Provider site
|3 Volltext
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK38701
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|